Gubra AS (STU:PI3) Notes Receivable: €0.0 Mil (As of Dec. 2025)


STU:PI3 Gubra AS STU:PI3
60 GF Score
Price €43.04
GF Value €379.79
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS Notes Receivable?

Gubra AS STU:PI3 -3.11% 60 Notes Receivable is €0.0 Mil as of Dec. 2025. GuruFocus rates STU:PI3 with a GF Score™ of 60/100 and a GF Value™ of €379.79 (Possible Value Trap). The stock has 3 warning signs investors should review.

Gubra AS's Notes Receivable for the quarter that ended in Dec. 2025 was €0.0 Mil.

Gubra AS Notes Receivable Historical Data

* Premium members only.

The historical data trend for Gubra AS's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS Notes Receivable Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:PI3
60GF Score
Gubra AS STU:PI3
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gubra AS Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.0 Mil mean?
Gubra AS (STU:PI3) has a Notes Receivable of €0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Gubra AS and its competitors.
Is Gubra AS's Notes Receivable too high?
Gubra AS's current Notes Receivable is €0.0 Mil. Overall, Gubra AS has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Notes Receivable compare to VRTX and REGN?
Gubra AS's Notes Receivable of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Gubra AS and its competitors. Gubra AS's current Notes Receivable is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (STU:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €379.79, compared to a current price of €43.04 — trading 88.7% below its estimated fair value. The current Notes Receivable is €0.0 Mil. Gubra AS's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Gubra AS (STU:PI3), the current Notes Receivable is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (STU:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €43.04 is trading 88.7% below its estimated GF Value™ of €379.79. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for STU:PI3:

  • Notes Receivable: €0.0 Mil
  • GF Value™: €379.79 vs. price of €43.04 (88.7% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the STU:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:Denmark
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
60GF Score

Get the complete analysis for STU:PI3

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.04
Price
€379.79
GF Value